Latest Carcinoma Stories
The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms(1,2) EAST HANOVER, N.J., June 1, 2014 /PRNewswire/
LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Minimally Invasive Procedure Showcases Future Treatment Options Pleasanton, CA (PRWEB) May 02, 2014 Sanarus Technologies welcomes the release of an abstract
Invasive bladder cancer (IBC), a malignant disease that currently affects more than 375,000 people worldwide, has been found to be caused by a single type of cell in the lining of the bladder, according to researchers with the Stanford University School of Medicine.
Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug,
Bladder cancer patients with metabolic syndrome – a set of conditions closely related to diabetes risk – are more likely to have a more invasive and fast-growing form of the disease.
ORPINGTON, England, March 27, 2014 /PRNewswire/ -- Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence
WOONSOCKET, R.I., March 20, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) has filed additional U.S.
- A trick or prank.